Thursday, September 26, 2024

NIH NEI RFP: eyeGENE® Specialized Medical Support – (e-Consent)

Notice ID: RFQ75N980Q6735423

Description

The National Ophthalmic Disease Genotyping and Phenotyping Network (eyeGENE®) is a research venture created by the National Eye Institute (NEI), part of the National Institutes of Health (NIH). eyeGENE® aims to advance studies of eye diseases and their genetic causes by giving researchers access to DNA samples, clinical information, and patients looking to participate in research studies and clinical trials.

Statement of Work (SOW) covers the implementation of an e-consent software solution. A web application is needed to provide participants the ability to review elements of the consent document(s), test participant consent comprehension and allows for electronic signature and the storage of consent records.

Tasks

Task 1. Platform hosting and maintenance – The platform license is inclusive of platform hosting and maintenance as follows:

  • High availability cloud hosting environment managed and monitored by Company
  • Management of the solution, to include all necessary software and hardware maintenance
  • Compliance with applicable standards, regulations and guidelines including those applicable to the federal government
  • System training and platform user guides

End user, site, and administer support

Task 2. Professional Service – Professional services in support of platform management, eConsent processing, distribution and management, content management and reporting. Professional Service are to be billed as time and materials. Platform Support Package includes:

  • Copyright and Creative Support
  • Language translations
  • Managed Services
  • Solution Enhancements
  • Training

Task 3. System Requirements – The list of requirements for the application functionality are as follows:

  • 21 CFR Part 11 compliance
  • WCAG 2/508 compliance…

Read more here.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

FedHealthIT Xtra – Find Out More!

Recent News

Don’t Miss A Thing

Subscribe to our mailing list

* indicates required